TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Gross Profit Margin (Quarterly) : 33.49% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.49% |
| March 31, 2026 | 29.43% |
| December 31, 2025 | 71.83% |
| September 30, 2025 | 69.45% |
| June 30, 2025 | 77.34% |
| March 31, 2025 | 68.77% |
| December 31, 2024 | -6.92% |
| September 30, 2024 | 2.10% |
| June 30, 2024 | -108.2% |
| March 31, 2024 | -121.6% |
| December 31, 2023 | 82.25% |
| Date | Value |
|---|---|
| September 30, 2023 | 66.92% |
| June 30, 2023 | 58.83% |
| March 31, 2023 | 77.97% |
| December 31, 2022 | 52.05% |
| September 30, 2022 | 62.80% |
| June 30, 2022 | 70.24% |
| March 31, 2022 | 60.44% |
| December 31, 2021 | 59.99% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 76.79% |
| March 31, 2021 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.52% |
| Return on Assets | -50.61% |
| Return on Invested Capital | -54.51% |
| Profit Margin (Quarterly) | -2.89K% |
| Operating Margin (Quarterly) | -2.90K% |
| Return on Net Operating Assets | -177.3% |